Randomized Phase II Crossover Study of Tiotropium For Dyspnea in Advanced Non-Small Cell Lung Cancer
The feeling of shortness of breath is very common in lung cancer. It is uncomfortable for
patients and upsetting for their family. Although drugs like morphine and oxygen can help
some patients feel better, they don't help everybody, and they are not used in patients with
early symptoms. More relief is needed for these patients. The investigators are studying a
drug called tiotropium, which is used in emphysema. It is an inhaler that opens the airways
to allow easier breathing. Every patient will get the drug but also a placebo, in a random
(flip of a coin) order. They will get each for 2 weeks. The investigators will see if they
feel better with the drug.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society